Unrecognized Tax Benefits of Ultragenyx Pharmaceutical Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Ultragenyx Pharmaceutical Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $111,000,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Ultragenyx Pharmaceutical Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $111,000,000 +$14,000,000 +14% 31 Dec 2025 10-K 18 Feb 2026 2025 FY
Q4 2024 $97,000,000 +$17,000,000 +21% 31 Dec 2024 10-K 18 Feb 2026 2025 FY
Q4 2023 $80,000,000 +$13,000,000 +19% 31 Dec 2023 10-K 18 Feb 2026 2025 FY
Q4 2022 $67,000,000 +$11,640,000 +21% 31 Dec 2022 10-K 18 Feb 2026 2025 FY
Q4 2021 $55,360,000 +$8,698,000 +19% 31 Dec 2021 10-K 19 Feb 2025 2024 FY
Q4 2020 $46,662,000 +$6,708,000 +17% 31 Dec 2020 10-K 21 Feb 2024 2023 FY
Q4 2019 $39,954,000 +$6,227,000 +18% 31 Dec 2019 10-K 17 Feb 2023 2022 FY
Q4 2018 $33,727,000 +$5,350,000 +19% 31 Dec 2018 10-K 15 Feb 2022 2021 FY
Q4 2017 $28,377,000 +$14,872,000 +110% 31 Dec 2017 10-K 12 Feb 2021 2020 FY
Q4 2016 $13,505,000 -$10,505,000 -44% 31 Dec 2016 10-K 14 Feb 2020 2019 FY
Q4 2015 $24,010,000 +$16,735,000 +230% 31 Dec 2015 10-K 20 Feb 2019 2018 FY
Q4 2014 $7,275,000 +$3,550,000 +95% 31 Dec 2014 10-K 21 Feb 2018 2017 FY
Q4 2013 $3,725,000 +$2,174,000 +140% 31 Dec 2013 10-K 17 Feb 2017 2016 FY
Q4 2012 $1,551,000 +$1,227,000 +379% 31 Dec 2012 10-K 26 Feb 2016 2015 FY
Q4 2011 $324,000 31 Dec 2011 10-K 27 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.